chrX-50069627-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000307367.2(CLCN5):c.-165C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0118 in 898,734 control chromosomes in the GnomAD database, including 812 homozygotes. There are 2,656 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.057 ( 497 hom., 1665 hem., cov: 23)
Exomes 𝑓: 0.0054 ( 315 hom. 991 hem. )
Consequence
CLCN5
ENST00000307367.2 5_prime_UTR
ENST00000307367.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.306
Genes affected
CLCN5 (HGNC:2023): (chloride voltage-gated channel 5) This gene encodes a member of the ClC family of chloride ion channels and ion transporters. The encoded protein is primarily localized to endosomal membranes and may function to facilitate albumin uptake by the renal proximal tubule. Mutations in this gene have been found in Dent disease and renal tubular disorders complicated by nephrolithiasis. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant X-50069627-C-G is Benign according to our data. Variant chrX-50069627-C-G is described in ClinVar as [Benign]. Clinvar id is 1245383.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.195 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CLCN5 | NM_001127898.4 | c.164-252C>G | intron_variant | ENST00000376091.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CLCN5 | ENST00000376091.8 | c.164-252C>G | intron_variant | 2 | NM_001127898.4 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0572 AC: 6364AN: 111163Hom.: 497 Cov.: 23 AF XY: 0.0499 AC XY: 1667AN XY: 33397
GnomAD3 genomes
AF:
AC:
6364
AN:
111163
Hom.:
Cov.:
23
AF XY:
AC XY:
1667
AN XY:
33397
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00537 AC: 4227AN: 787518Hom.: 315 Cov.: 23 AF XY: 0.00444 AC XY: 991AN XY: 223054
GnomAD4 exome
AF:
AC:
4227
AN:
787518
Hom.:
Cov.:
23
AF XY:
AC XY:
991
AN XY:
223054
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0572 AC: 6361AN: 111216Hom.: 497 Cov.: 23 AF XY: 0.0498 AC XY: 1665AN XY: 33460
GnomAD4 genome
AF:
AC:
6361
AN:
111216
Hom.:
Cov.:
23
AF XY:
AC XY:
1665
AN XY:
33460
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 18, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at